Ethaninidothioic acid (R5421) is not a selective inhibitor of platelet phospholipid scramblase activity.
Autor: | Millington-Burgess SL; Department of Pharmacology, University of Cambridge, Cambridge, UK., Bonna AM; CambCol Laboratories, Ely, Cambridgeshire, UK., Rahman T; Department of Pharmacology, University of Cambridge, Cambridge, UK., Harper MT; Department of Pharmacology, University of Cambridge, Cambridge, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | British journal of pharmacology [Br J Pharmacol] 2020 Sep; Vol. 177 (17), pp. 4007-4020. Date of Electronic Publication: 2020 Jun 30. |
DOI: | 10.1111/bph.15152 |
Abstrakt: | Background and Purpose: Ethaninidothioic acid (R5421) has been used as a scramblase inhibitor to determine the role of phospholipid scrambling across a range of systems including platelet procoagulant activity. The selectivity of R5421 has not been thoroughly studied. Here, we characterised the effects of R5421 on platelet function and its suitability for use as a scramblase inhibitor. Experimental Approach: Human platelet activation was measured following pretreatment with R5421 and stimulation with a range of agonists. Phosphatidylserine exposure was measured using annexin V binding. Integrin α Key Results: R5421 inhibited A23187-induced phosphatidylserine exposure in a time- and temperature-dependent manner. R5421 inhibited Ca 2+ signalling from the PAR1, PAR4 and glycoprotein VI receptors as well as platelet α Conclusion and Implications: R5421 is not a selective inhibitor of platelet scramblase activity. We have identified the pesticide thiodicarb, which had similar effects on platelet function to R5421 as well as additional disruption of Ca 2+ signalling which may underlie some of thiodicarb's toxicity. (© 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |